Denise P. Milot - Concepedia

Author

Denise P. Milot

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Denise Milot, Denise P. Milot

Publications

768

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Denise P. Milot is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	597
2	Biochemistry	8	8	475
3	Natural Sciences	4	4	182
4	Health Sciences	3	3	297
5	Engineering	1	1	24

Denise P. Milot

Publications

746

Citations

H-Index

Page 1

	Year	Citations
Different roles of liver X receptor α and β in lipid metabolism: Effects of an α-selective and a dual agonist in mice deficient in each subtype Erik Lund, Laurence B. Peterson, Alan D. Adams, Biochemical Pharmacology Molecular PharmacologyMolecular PhysiologyBiochemistryMedicineLiver Physiology	2005	143
Biochemical characterization of cholesteryl ester transfer protein inhibitors Mollie Ranalletta, Kathleen K. Bierilo, Ying Chen, Journal of Lipid Research	2010	96
PPARα Agonists Reduce 11β-Hydroxysteroid Dehydrogenase Type 1 in the Liver Anne Hermanowski‐Vosatka, David Gerhold, Steven S. Mundt, Biochemical and Biophysical Research Communications Molecular PhysiologyAldehyde DehydrogenaseBiochemistryMedicineLiver Physiology	2000	95
Biphenyl-Substituted Oxazolidinones as Cholesteryl Ester Transfer Protein Inhibitors: Modifications of the Oxazolidinone Ring Leading to the Discovery of Anacetrapib Cameron J. Smith, Amjad Ali, Milton L. Hammond, Journal of Medicinal Chemistry Oxazolidinone RingMedicinal ChemistryMethyl GroupPharmaceutical SciencePharmacological Study	2011	68
Regulation of lipid metabolism and gene expression by fenofibrate in hamsters Qiu Guo, Pei-Ran Wang, Denise P. Milot, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids Animal PhysiologyBiochemistryLipid MetabolismMedicineNatural Sciences	2001	61
High fat fed hamster, a unique animal model for treatment of diabetic dyslipidemia with peroxisome proliferator activated receptor alpha selective agonists Pei-Ran Wang, Qiu Guo, Marc C. Ippolito, European Journal of Pharmacology Metabolic SyndromeBiochemistryMedicineUnique Animal ModelDiabetes	2001	59
2-Arylbenzoxazoles as CETP inhibitors: Substitution of the benzoxazole moiety Cameron J. Smith, Amjad Ali, Liya Chen, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryHeterocyclicBenzoxazole MoietyNatural SciencesMedicine	2009	40
A Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist Demonstrates Favorable Effects on Lipid Homeostasis Qiu Guo, Soumya P. Sahoo, Pei-Ran Wang, Endocrinology	2004	40
2-Arylbenzoxazoles as CETP inhibitors: Raising HDL-C in cynoCETP transgenic mice Florida Kallashi, Dooseop Kim, Jennifer E. Kowalchick, Bioorganic & Medicinal Chemistry Letters MedicineCetp InhibitorsPharmacological AgentCellular PharmacologyPharmacotherapy	2010	28
2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety Julianne A. Hunt, Silvia González, Florida Kallashi, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryEngineeringMedicineDrug DiscoveryOrganic Chemistry	2009	24

Page 1